Skip to content

Implementation Research on the Intervention Mode of Comorbidity-Co-causes-Joint-prevention Comprehensive Demonstration District of Depression and Obesity Among Children and Adolescents in Beijing

Implementation Research on the Intervention Mode of Comorbidity-Co-causes-Joint-prevention Comprehensive Demonstration District of Depression and Obesity Among Children and Adolescents in Beijing

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06489990
Enrollment
440
Registered
2024-07-08
Start date
2024-08-01
Completion date
2026-12-31
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, High Risk of Depression, Obesity, Overweight

Keywords

children, adolescents, depression, obesity, effectiveness evaluation, intervention mode

Brief summary

Depression and obesity have become the most prominent health problems among adolescents and have caused a heavy burden on the health and social economy of the whole population. There are high incidence, comorbidity and co-pathogenic factors of depression and obesity in adolescents, but there is still a lack of research on joint prevention strategies and multi-sectoral collaborative prevention and control network. This project plans to screen and integrate effective intervention measures based on multi-stage optimization strategy, developing an intervention mode of \[Comorbidity-Co-causes-Joint-prevention\] for adolescents with depression or/and obesity, and then carry out with children or adolescents in Beijing based on digital platform. The investigators will be considering the accessibility, sustainability and replicability of the implement based on the RE-AIM framework including the coverage of population and organizations as well as the effect, implement and sustainability of the interventions. The research will be promoted with the help of the National Clinical Research Center for Mental Disorders and Monitoring of Student Common Diseases and Health Influencing Factors. The results of the research will establish an intervention mode of \[Comorbidity-Co-causes-Joint-prevention\] and a promotion model for adolescents' depression and obesity in Beijing, providing support for the realization of Healthy China 2030 and Healthy Beijing 2030 Plans.

Interventions

COMBINATION_PRODUCTcombination intervention strategy of [Comorbidity-Co-causes-Joint-prevention]

combination intervention strategy of \[Comorbidity-Co-causes-Joint-prevention\]

COMBINATION_PRODUCTroutine health education and mental health knowledge

routine health education and mental health knowledge

Sponsors

Peking University
CollaboratorOTHER
Center for Disease Control and Prevention of Bejing Economic-Technoloogical Develeopment Area
CollaboratorUNKNOWN
Capital Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Stage I (screening stage): 1. Middle school students in Beijing Economic-Technological Development Area and other districts of Beijing, both male and female; 2. Students themselves and their guardians are willing to participate in this study and sign written informed consent file. Stage Ⅱ: Middle school students who were identified as high risk of depression and/or obesity in Stage I in Beijing Economic-Technological Development Area and other districts of Beijing, the screening criteria are as follows: ① CES-DC score ≥16 points; ② BMI ≥WS/T586-2018: Screened as overweight and obesity among school-age children and adolescents, according to the recommendation by the National Health Commission; ③ Students themselves and their guardians are willing to participate in this study and provide written informed consent.

Exclusion criteria

* Stage I: 1. Having serious physical or genetic disease that is not suitable for participation in the study; 2. Have been evaluated that not suitable for this study by investigators. Stage Ⅱ: 1. Having serious physical or genetic disease that is not suitable for participation in the study; 2. Have been evaluated that not suitable for this study by investigators.

Design outcomes

Primary

MeasureTime frameDescription
Patient Health Questionnaire-9(PHQ-9)From enrollment to the end of treatment at baseline、12weeks、6monthsThe score ranges from 0 to 27, the higher scores mean more serious depression

Secondary

MeasureTime frame
BMIFrom enrollment to the end of treatment at baseline、12 weeks、6months

Countries

China

Contacts

Primary ContactLinghui Meng, PHD
linghuimeng@mail.ccmu.edu.cn86 18210344972
Backup ContactPingping Gui
guipingping2022@163.com86 13253610521

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026